Press releases
- MindMed to Participate at May Investor Conferences
- New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US
- MindMed Reports First Quarter 2024 Financial Results and Business Updates
- MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York
- MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update
- MindMed to Present at Upcoming May Medical Conferences
- MindMed to Present at Upcoming April Medical Conferences
- MindMed Announces Voluntary Delisting from Cboe Canada
- MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference
- Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement
More ▼
Key statistics
On Friday, Mind Medicine (MindMed) Inc (MMQ:DUS) closed at 8.33, -29.03% below its 52-week high of 11.73, set on Apr 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.38 |
---|---|
High | 8.40 |
Low | 8.33 |
Bid | 8.48 |
Offer | 8.63 |
Previous close | 8.25 |
Average volume | 931.60 |
---|---|
Shares outstanding | 71.87m |
Free float | 69.95m |
P/E (TTM) | -- |
Market cap | 655.48m USD |
EPS (TTM) | -2.45 USD |
Data delayed at least 15 minutes, as of May 10 2024 18:32 BST.
More ▼